Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
KKR’s PharMerica Makes Its First Deal
In late May, specialty pharmacy company PharMerica Corporation announced its first acquisition since being acquired by KKR & Co. (NYSE: KKR), with a minority investment from Walgreens Boots Alliance (NASDAQ: WBA), in August 2017. The company priovides institutional and community-based pharmacy services in the United States. When KKR took it private for $1.3 billion, it had trailing-12 month revenue of approximately $2.4 billion and EBITDA of $138 million. In December 2018, KKR announced a $1.3 billion deal for BrightSpring Health Services, then owned by Onex Corporation (ONEX.TO). BrightSpring, formerly known as ResCare, provides comprehensive home and community-based health services... Read More »
MyEyeDr Acquired by Goldman Sachs’ PE Firm
West Street Capital Partners VII, the private equity arm of Goldman Sachs (NYSE: GS), dove into the ophthalmology market with its $2.6 billion deal for privately held Capital Vision Services. If that name doesn’t sound familiar, its operating trade name might ring a bell: MyEyeDr. The sellers were Altas Partners LP and Canadian pension fund Caisse de dépôt et placement du Québec (CDPQ), which paid $775 million to acquire the physician network in 2015. At the time, MyEyeDr had only 165 physicians in seven states. The company expects to have 575 practices in 18 states by the end of 2019. Ophthalmology practices continue to be a hot commodity, especially for PE firms. The eye care... Read More »
Private Equity Stays Active in Health Care
Nearly halfway into 2019, and PE firms are showing no signs of slowing as they swarm the healthcare industry. So far this year, there have been 71 deals with a private equity firm as the buyer, or roughly 11% of the total deals announced. That’s roughly the same amount as in the same period in 2018. In late May, Golden Gate Capital announced it purchased Ensemble Health Partners for a reported $1.2 billion from Bon Secours Mercy Health. The target company provides outsourced revenue cycle management (RCM) and operation solutions to hospitals across the country. It has more than 3,600 employees and partners with more than 60 hospitals in 30 states. Bon Secours bought the company in... Read More »
Lumos Diagnostics Bolsters its POC Testing Platform
Lumos Diagnostics, a subsidiary of Planet Innovation, announced this week it acquired RPS Diagnostics for an undisclosed price. RPS develops, manufactures and markets rapid, point-of-care diagnostic tests for a variety of infectious diseases and inflammatory conditions. The merged company will be called Lumos Diagnostics. This deal adds RPS’s FebriDx test, a rapid, in-office test that provides clinicians with a rapid assessment of the body’s immune response to an acute respiratory infection. Combining RPS’ biomarker technology and Lumos’ reader-based platform will create a strong pipeline of products. This deal caps off a relatively busy month for the laboratories, MRI... Read More »
Health Care M&A Deals, Week Ending May 31, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Anji Pharmaceuticals, Inc. Global rights to Metformin DR N/A Eli Lilly and Company Exclusive worldwide rights to CNTX-0290 $47,500,000 Constellation Alpha Capital Corp. DermTech, Inc. $15,000,000 eHealth Acquirer Target Price Apple Inc. Tueo Health... Read More »
Community Health Systems Sells Three More Hospitals
Community Health Systems (NYSE: CYH) is still at it. The financially troubled hospital chain unloaded three more hospitals in May, bringing the number of divested facilities in 2019 to seven. The latest announcements involved two Florida hospitals, Heart of Florida Regional Medical Center (193 beds) in Davenport and Lake Wales Medical Center (160 beds) in Lake Wales, along with their respective assets, physician clinic operations and outpatient services. The acquirer is AdventHealth, formerly known as Adventist Health System, a not-for-profit healthcare system with 45 hospital campuses and more than 8,200 licensed beds in nine states. Lake Wales Medical Center has been struggling... Read More »
WVU Health Adds The Health Plan to its Roster
Hospitals and health systems typically buy outpatient services such as urgent care and ambulatory surgery centers to raise their market presence. West Virginia University Health System (WVU Health), a not-for-profit system based in Morgantown, West Virginia, instead has merged with The Health Plan, a community-based not-for-profit health maintenance organization that offers Medicare Advantage, Medicaid, Point-of-Service and Preferred Provider Organization plans. Based in Wheeling, it has licenses in West Virginia’s 55 counties, as well as a 36-county area in Ohio. WVU Health is the state’s largest health system with nine hospitals in the state and one in Oakland, Maryland. It... Read More »
EMR Software Provider Acquired by WELL Health
Slowly but surely, WELL Health Technologies Corp. (TSX.V: WELL) is building its own digital health platform. The Canadian healthcare operator announced it acquired OSCARprn for $876,000. Financial details include $619,500 upfront and $256,500 via 373,906 shares in the capital of WELL at a price of approximately $0.69 per share. The target company provides electronic medical record (EMR) software services compatible with Oscar, an open source EMR platform that handles patient records, scheduling, prescription management, and billing. OSCARprn partners with approximately 71 medical clinics in British Columbia, approximately 820 practitioners, and over 800,000 unique patients. This eHealth... Read More »
Another Cancer Treatment Startup for Merck
Merck & Co., Inc. (NYSE: MRK) has been busy this year. After securing a licensing deal with Cocrystal (NASDAQ: COCP) for proprietary influenza A/B antiviral agents in January, the company found two biotechnology start-ups to bolster its cancer treatment portfolio. First, in February Merck bought Immune Design for $5.85 per share in cash, for an approximate value of $300 million (135.8x trailing 12-month revenue). The target company is a late-stage immunotherapy company employing in-vivo approaches to enable the body’s immune system to fight disease. Through this acquisition, Merck gained Immune Design’s proprietary technologies, GLAAS and ZVex, which are engineered to... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
